Farmako logo
HomeMedicine DeliveryABDM
Decorative illustration
HomeMedicine DeliveryABDM
footer illustration
Home
About UsRefund & CancellationProduct / Service Details
Contact UsDelivery & Shipping PolicyPrivacy Policy
Download the App
play-storeapp-store
Copyright Farmako Healthcare Private Limited © 2025 All rights reserved
facebooktwitterlinkedininstagram
medicine

Glimwin-M1 Tablet ER

strip of 10.0 tablet
Prescription Required
30 minute delivery
strip of 10.0 tablet
₹ 40.38
Get it on upto a 20% discount on Farmako
Delivering to
Out of Stock
Ask Life AI anything about this medicine
Tell me about medicines!

Manufacturer

Healthkind Labs Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Key InformationDirections for UseSafety InformationHow it worksQuick Tips

Manufacturer

Healthkind Labs Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Key Information

Short Description

Glimwin-M1 Tablet ER is a combination of two medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.

Dosage Form

Tablet ER

Introduction

Glimwin-M1 Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.

Directions for Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimwin-M1 Tablet ER is to be taken with food.

Safety Information

Side Effects

Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea vomiting and stomach pain as Glimwin-M1 Tablet ER may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood.

Alcohol Warning

Alcohol Warning

It is unsafe to consume alcohol with Glimwin-M1 Tablet ER.

Breastfeeding Warning

Breastfeeding Warning

Glimwin-M1 Tablet ER is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Pregnancy Warning

Pregnancy Warning

Glimwin-M1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

How it works

Glimwin-M1 Tablet ER is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.

Quick Tips

Take it with food to lower your chance of having an upset stomach. Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Glimwin-M1 Tablet ER may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.

Short Description

Glimwin-M1 Tablet ER is a combination of two medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.

Dosage Form

Tablet ER

Introduction

Glimwin-M1 Tablet ER belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimwin-M1 Tablet ER is to be taken with food.

Side Effects

Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea vomiting and stomach pain as Glimwin-M1 Tablet ER may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood.
Alcohol Warning

Alcohol Warning

It is unsafe to consume alcohol with Glimwin-M1 Tablet ER.
Breastfeeding Warning

Breastfeeding Warning

Glimwin-M1 Tablet ER is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy Warning

Pregnancy Warning

Glimwin-M1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimwin-M1 Tablet ER is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Take it with food to lower your chance of having an upset stomach. Monitor your blood sugar level regularly while you are taking this medicine. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting, and stomach pain as Glimwin-M1 Tablet ER may cause a rare but serious condition called lactic acidosis, which is an excess of lactic acid in the blood.

Related Medicines

medicine

Ozomet G1 Tablet

1 Strip of 15 Tablet
20% off1 Strip of 15 Tablet
₹ 48.31
20% off
medicine

Ixoglime GM 1 Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 52.00
20% off
medicine

Diberyl M 1mg/500mg Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 45.80
20% off
medicine

Glifur G 1mg/500mg Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 40.30
20% off
medicine

Glilar M 1 Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 40.80
20% off
medicine

Touchpride M 1mg/500mg Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 65.00
20% off
medicine

Glimefine M 1 Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 36.00
20% off
medicine

Numglim MF 1mg/500mg Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 44.54
20% off
medicine

Glimymed M 1mg/500mg Tablet ER

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 45.00
20% off
medicine

Timer 1 ER Tablet

strip of 10.0 tablet
20% offstrip of 10.0 tablet
₹ 82.00
20% off

Frequently asked questions

What are the recommended storage conditions for Glimwin-M1 Tablet ER?

Store Glimwin-M1 Tablet ER in its original container, tightly closed, according to the instructions on the packaging. Dispose of any unused medication responsibly and keep it out of reach of children, pets, and other individuals.

Can the use of Glimwin-M1 Tablet ER lead to lactic acidosis?

Yes, the use of Glimwin-M1 Tablet ER can cause a rare but serious condition called metformin-associated lactic acidosis (MALA). This is characterized by increased levels of lactic acid in the blood and may occur more frequently in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain, weakness, dizziness, nausea, vomiting, abdominal pain, slow heart rate, and feeling cold in arms and legs. If you experience these symptoms, discontinue use and consult your doctor immediately.

What is Glimwin-M1 Tablet ER?

Glimwin-M1 Tablet ER is a combination medication containing glimepiride and metformin. It is used in the treatment of type 2 diabetes mellitus (DM) to improve blood glucose levels in adults when combined with a proper diet and regular exercise. Glimepiride works by increasing insulin release from the pancreas, while metformin reduces glucose production in the liver and improves insulin sensitivity.

What are the possible side effects of Glimwin-M1 Tablet ER?

Common side effects associated with the use of Glimwin-M1 Tablet ER include hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects may include lactic acidosis and Vitamin B12 deficiency on long-term use.

Can the use of Glimwin-M1 Tablet ER lead to Vitamin B12 deficiency?

Yes, the prolonged use of Glimwin-M1 Tablet ER can cause a deficiency in Vitamin B12. This may lead to anemia and nerve problems if left untreated, manifesting as tingling sensation and numbness in hands and feet, weakness, urinary issues, changes in mental status, and difficulty maintaining balance (ataxia). It is recommended that patients receive Vitamin B12 supplementation from outside sources at least once a year.

Can the use of Glimwin-M1 Tablet ER cause hypoglycemia?

Yes, the use of Glimwin-M1 Tablet ER can lead to low blood sugar levels (hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This risk is higher when missing or delaying meals, consuming alcohol, over-exercising, or taking other antidiabetic medications simultaneously.

Is it safe to take alcohol while I am also taking Glimwin-M1 Tablet ER?

No, it is not recommended to consume alcohol while using Glimwin-M1 Tablet ER as it can lower blood sugar levels and increase the risk of hypoglycemia and lactic acidosis.

Store Glimwin-M1 Tablet ER in its original container, tightly closed, according to the instructions on the packaging. Dispose of any unused medication responsibly and keep it out of reach of children, pets, and other individuals.
Yes, the use of Glimwin-M1 Tablet ER can cause a rare but serious condition called metformin-associated lactic acidosis (MALA). This is characterized by increased levels of lactic acid in the blood and may occur more frequently in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain, weakness, dizziness, nausea, vomiting, abdominal pain, slow heart rate, and feeling cold in arms and legs. If you experience these symptoms, discontinue use and consult your doctor immediately.
Glimwin-M1 Tablet ER is a combination medication containing glimepiride and metformin. It is used in the treatment of type 2 diabetes mellitus (DM) to improve blood glucose levels in adults when combined with a proper diet and regular exercise. Glimepiride works by increasing insulin release from the pancreas, while metformin reduces glucose production in the liver and improves insulin sensitivity.
Common side effects associated with the use of Glimwin-M1 Tablet ER include hypoglycemia (low blood sugar), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects may include lactic acidosis and Vitamin B12 deficiency on long-term use.
Yes, the prolonged use of Glimwin-M1 Tablet ER can cause a deficiency in Vitamin B12. This may lead to anemia and nerve problems if left untreated, manifesting as tingling sensation and numbness in hands and feet, weakness, urinary issues, changes in mental status, and difficulty maintaining balance (ataxia). It is recommended that patients receive Vitamin B12 supplementation from outside sources at least once a year.
Yes, the use of Glimwin-M1 Tablet ER can lead to low blood sugar levels (hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This risk is higher when missing or delaying meals, consuming alcohol, over-exercising, or taking other antidiabetic medications simultaneously.
No, it is not recommended to consume alcohol while using Glimwin-M1 Tablet ER as it can lower blood sugar levels and increase the risk of hypoglycemia and lactic acidosis.
India' first 30 minutes
medicine delivery service
percentage
Get atleast 20% discount on all medicines
shield
We always ensure genuine medicines and qualified doctors
deliver
Completed over 2 lakhs super-fast deliveries